Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated ileum and colon

R. Patacchini, S. Giuliani, M. Lazzeri, A. Turini, L. Quartara, C. A. Maggi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The affinities of the monocyclic pseudopeptides MEN10,508, MEN10,573, MEN10,581, MEN10,612, MEN10,619 and MEN10,677, and the bicyclic peptides MEN10,627, MEN10,692, MEN10,771, MEN10,882 and MEN10,993 were evaluated at the tachykinin NK2 receptors of the human isolated ileum and colon circular muscle preparations, by using [βAla8]neurokinin A(4-10) as an agonist. All of the antagonists tested produced a concentration-dependent and competitive antagonism of [βAla8]neurokininA(4-10)-mediated contractions in both preparations. MEN10,612 (pK(B) = 8.1) and MEN10,627 (pK(B) = 8.4-8.8) were among the most potent analogs within their chemical classes. In general, the bicyclic peptide antagonists were more potent than the monocyclic peptide compounds, showing a nanomolar affinity for the human NK2 receptor. By comparing the affinities shown by the antagonists under study at NK2 receptors of the human gut with the affinities measured at NK2 receptors of the rabbit isolated pulmonary artery and hamster isolated trachea, a high degree of pharmacological homology was found between human and rabbit NK2 receptors. The present results point out the class of NK2 receptor antagonists bearing a bicyclic peptide structure, like MEN10,627, as candidates for testing in pathological conditions characterized by exaggerated gut motility, in which tachykinins might play a role as non-cholinergic excitatory neurotransmitters.

Original languageEnglish
Pages (from-to)71-77
Number of pages7
JournalNeuropeptides
Volume31
Issue number1
DOIs
Publication statusPublished - 1997

Fingerprint

Tachykinin Receptors
Tachykinins
Cyclic Peptides
Ileum
Colon
Peptides
Bearings (structural)
Rabbits
Trachea
Cricetinae
Pulmonary Artery
Neurotransmitter Agents
Muscle
Pharmacology
Muscles
Testing

ASJC Scopus subject areas

  • Endocrinology
  • Clinical Neurology
  • Endocrinology, Diabetes and Metabolism
  • Cellular and Molecular Neuroscience
  • Neuroscience(all)
  • Biochemistry

Cite this

Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated ileum and colon. / Patacchini, R.; Giuliani, S.; Lazzeri, M.; Turini, A.; Quartara, L.; Maggi, C. A.

In: Neuropeptides, Vol. 31, No. 1, 1997, p. 71-77.

Research output: Contribution to journalArticle

Patacchini, R. ; Giuliani, S. ; Lazzeri, M. ; Turini, A. ; Quartara, L. ; Maggi, C. A. / Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated ileum and colon. In: Neuropeptides. 1997 ; Vol. 31, No. 1. pp. 71-77.
@article{b03a478a67da4d1184efa374531a2649,
title = "Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated ileum and colon",
abstract = "The affinities of the monocyclic pseudopeptides MEN10,508, MEN10,573, MEN10,581, MEN10,612, MEN10,619 and MEN10,677, and the bicyclic peptides MEN10,627, MEN10,692, MEN10,771, MEN10,882 and MEN10,993 were evaluated at the tachykinin NK2 receptors of the human isolated ileum and colon circular muscle preparations, by using [βAla8]neurokinin A(4-10) as an agonist. All of the antagonists tested produced a concentration-dependent and competitive antagonism of [βAla8]neurokininA(4-10)-mediated contractions in both preparations. MEN10,612 (pK(B) = 8.1) and MEN10,627 (pK(B) = 8.4-8.8) were among the most potent analogs within their chemical classes. In general, the bicyclic peptide antagonists were more potent than the monocyclic peptide compounds, showing a nanomolar affinity for the human NK2 receptor. By comparing the affinities shown by the antagonists under study at NK2 receptors of the human gut with the affinities measured at NK2 receptors of the rabbit isolated pulmonary artery and hamster isolated trachea, a high degree of pharmacological homology was found between human and rabbit NK2 receptors. The present results point out the class of NK2 receptor antagonists bearing a bicyclic peptide structure, like MEN10,627, as candidates for testing in pathological conditions characterized by exaggerated gut motility, in which tachykinins might play a role as non-cholinergic excitatory neurotransmitters.",
author = "R. Patacchini and S. Giuliani and M. Lazzeri and A. Turini and L. Quartara and Maggi, {C. A.}",
year = "1997",
doi = "10.1016/S0143-4179(97)90023-8",
language = "English",
volume = "31",
pages = "71--77",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "1",

}

TY - JOUR

T1 - Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated ileum and colon

AU - Patacchini, R.

AU - Giuliani, S.

AU - Lazzeri, M.

AU - Turini, A.

AU - Quartara, L.

AU - Maggi, C. A.

PY - 1997

Y1 - 1997

N2 - The affinities of the monocyclic pseudopeptides MEN10,508, MEN10,573, MEN10,581, MEN10,612, MEN10,619 and MEN10,677, and the bicyclic peptides MEN10,627, MEN10,692, MEN10,771, MEN10,882 and MEN10,993 were evaluated at the tachykinin NK2 receptors of the human isolated ileum and colon circular muscle preparations, by using [βAla8]neurokinin A(4-10) as an agonist. All of the antagonists tested produced a concentration-dependent and competitive antagonism of [βAla8]neurokininA(4-10)-mediated contractions in both preparations. MEN10,612 (pK(B) = 8.1) and MEN10,627 (pK(B) = 8.4-8.8) were among the most potent analogs within their chemical classes. In general, the bicyclic peptide antagonists were more potent than the monocyclic peptide compounds, showing a nanomolar affinity for the human NK2 receptor. By comparing the affinities shown by the antagonists under study at NK2 receptors of the human gut with the affinities measured at NK2 receptors of the rabbit isolated pulmonary artery and hamster isolated trachea, a high degree of pharmacological homology was found between human and rabbit NK2 receptors. The present results point out the class of NK2 receptor antagonists bearing a bicyclic peptide structure, like MEN10,627, as candidates for testing in pathological conditions characterized by exaggerated gut motility, in which tachykinins might play a role as non-cholinergic excitatory neurotransmitters.

AB - The affinities of the monocyclic pseudopeptides MEN10,508, MEN10,573, MEN10,581, MEN10,612, MEN10,619 and MEN10,677, and the bicyclic peptides MEN10,627, MEN10,692, MEN10,771, MEN10,882 and MEN10,993 were evaluated at the tachykinin NK2 receptors of the human isolated ileum and colon circular muscle preparations, by using [βAla8]neurokinin A(4-10) as an agonist. All of the antagonists tested produced a concentration-dependent and competitive antagonism of [βAla8]neurokininA(4-10)-mediated contractions in both preparations. MEN10,612 (pK(B) = 8.1) and MEN10,627 (pK(B) = 8.4-8.8) were among the most potent analogs within their chemical classes. In general, the bicyclic peptide antagonists were more potent than the monocyclic peptide compounds, showing a nanomolar affinity for the human NK2 receptor. By comparing the affinities shown by the antagonists under study at NK2 receptors of the human gut with the affinities measured at NK2 receptors of the rabbit isolated pulmonary artery and hamster isolated trachea, a high degree of pharmacological homology was found between human and rabbit NK2 receptors. The present results point out the class of NK2 receptor antagonists bearing a bicyclic peptide structure, like MEN10,627, as candidates for testing in pathological conditions characterized by exaggerated gut motility, in which tachykinins might play a role as non-cholinergic excitatory neurotransmitters.

UR - http://www.scopus.com/inward/record.url?scp=0031058711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031058711&partnerID=8YFLogxK

U2 - 10.1016/S0143-4179(97)90023-8

DO - 10.1016/S0143-4179(97)90023-8

M3 - Article

VL - 31

SP - 71

EP - 77

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 1

ER -